
USFDA APPLICATION NUMBER - 21585 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| GUAIFENESIN(UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) | GUAIFENESIN | 600mg |
| PSEUDOEPHEDRINE HYDROCHLORIDE(UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) | PSEUDOEPHEDRINE HYDROCHLORIDE | 60mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | REMEDYREPACK INC. | Amerisource Bergen | DZA Brands LLC | HyVee Inc | L. Perrigo Company | CVS Pharmacy | H E B | Kroger Company | Perrigo New York Inc | Strategic Sourcing Services LLC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |||||||||||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)(HHT01ZNK31) | |||||||||||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||||||||||
| COPOVIDONE K25-31(D9C330MD8B) | |||||||||||
| FD&C YELLOW NO. 6(H77VEI93A8) | |||||||||||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |||||||||||
| HYPROMELLOSES(3NXW29V3WO) | |||||||||||
| MAGNESIUM STEARATE(70097M6I30) | |||||||||||
| MALTODEXTRIN(7CVR7L4A2D) | |||||||||||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||||||||||
| POVIDONE, UNSPECIFIED(FZ989GH94E) | |||||||||||
| POVIDONES(FZ989GH94E) | |||||||||||
| SILICON DIOXIDE(ETJ7Z6XBU4) | |||||||||||
| STEARIC ACID(4ELV7Z65AP) |